| Estrogen and related hormone effects | Lifetime | 37 | JP 2 | 99.73 |
| Hormonal Regulation and Hypertension | Lifetime | 39 | JP 2 | 99.64 |
| Adrenal and Paraganglionic Tumors | Lifetime | 19 | JP 1 | 99.68 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 138 | JP 4 | 99.49 |
| Adrenal Hormones and Disorders | Lifetime | 47 | JP 1 | 99.10 |
| Breast Cancer Treatment Studies | Lifetime | 226 | JP 4 | 99.25 |
| HER2/EGFR in Cancer Research | Lifetime | 183 | JP 6 | 99.17 |
| Neuroendocrine Tumor Research Advances | Lifetime | 253 | JP 11 | 98.95 |
| Ovarian cancer diagnosis and treatment | Lifetime | 230 | JP 6 | 98.88 |
| Lung Cancer Research Studies | Lifetime | 350 | JP 22 | 98.62 |
| Sexual Differentiation and Disorders | Lifetime | 164 | JP 2 | 98.52 |
| Hormonal and reproductive studies | Lifetime | 371 | JP 1 | 98.06 |
| Breast Lesions and Carcinomas | Lifetime | 221 | JP 5 | 98.30 |
| Endometrial and Cervical Cancer Treatments | Lifetime | 369 | JP 12 | 98.19 |
| Neuroblastoma Research and Treatments | Lifetime | 406 | JP 4 | 97.79 |
| Pituitary Gland Disorders and Treatments | Lifetime | 402 | JP 12 | 97.82 |
| Cardiac tumors and thrombi | Lifetime | 284 | JP 13 | 97.31 |
| Cancer Cells and Metastasis | Lifetime | 677 | JP 34 | 97.29 |
| Cancer-related Molecular Pathways | Lifetime | 955 | JP 50 | 97.02 |
| Pharmacogenetics and Drug Metabolism | Lifetime | 578 | JP 32 | 96.87 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | Lifetime | 199 | JP 19 | 95.38 |
| Reproductive System and Pregnancy | Lifetime | 1,000 | JP 54 | 95.94 |
| Angiogenesis and VEGF in Cancer | Lifetime | 908 | JP 71 | 95.27 |
| Advanced Breast Cancer Therapies | Lifetime | 696 | JP 23 | 94.50 |
| Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities | Lifetime | 765 | JP 65 | 94.70 |
| Cancer and Skin Lesions | Lifetime | 885 | JP 58 | 94.13 |
| Steroid Chemistry and Biochemistry | Lifetime | 361 | JP 40 | 93.49 |
| Aldose Reductase and Taurine | Lifetime | 591 | JP 68 | 87.98 |
| 14-3-3 protein interactions | Lifetime | 736 | JP 73 | 79.76 |
| Male Breast Health Studies | Lifetime | 600 | JP 3 | 64.01 |
| Mechanisms of cancer metastasis | Lifetime | 835 | JP 96 | 61.38 |
| Hormonal Regulation and Hypertension | 2021-2025 | 96 | JP 6 | 95.99 |
| Adrenal and Paraganglionic Tumors | 2021-2025 | 87 | JP 3 | 96.11 |
| Neuroendocrine Tumor Research Advances | 2021-2025 | 371 | JP 21 | 92.84 |
| Lung Cancer Research Studies | 2021-2025 | 552 | JP 32 | 93.78 |
| Estrogen and related hormone effects | 2021-2025 | 217 | JP 2 | 88.03 |
| Adrenal Hormones and Disorders | 2021-2025 | 269 | JP 20 | 85.08 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | 2021-2025 | 237 | JP 13 | 65.21 |
